Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.
Prescriptions for broad-spectrum antibiotics fell when clinicians were intercepted by a risk-assessment prompt.
A multisite collaborative increases appropriate antibiotic use for pediatric community-acquired pneumonia, skin and soft ...
Transfer of bacteria between sick pets and their humans may be contributing to antibiotic resistance, according to new ...
The Food and Drug Administration recently approved Pivya (pivmecillinam) to treat uncomplicated UTIs in female adults.
The US Food and Drug Administration has approved pivmecillinam (Pivya) tablets to treat uncomplicated urinary tract ...
"The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective, and Pivya will ...
Yale researchers say that nasal application of neomycin shows promise in the prevention and treatment of respiratory viral ...
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
The U.S. Food and Drug Administration has approved Pivya (pivmecillinam) tablets for the treatment of female adults with ...
Camanchaca CEO Ricardo Garcia said the biggest factor preventing the attainment of the antibiotic-reduction goal has been the ...
Intranasal administration of neomycin sulfate in murine models shows promise as a prophylactic and therapeutic agent against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results